to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The National Institutes of Health has billions of dollars designated for biotech research. Read about how to win NIH research grants.
Securing venture capital can be a guessing game of trying to decide whether an investment will come through or not. Read about how you can work to get a positive answer and how you can tell if the answer may be a negative one.
Universities are finding innovative ways to commercialize technology with startup incubators, partnerships and other avenues. Read more about university technology transfer.
Life sciences business owners are seeing a modest rise in venture capital funds – no mean feat in this economy. But one big communications mistake will take you and your firm out of the running.
Is venture capital still viable as a model for funding new bioscience research, products and businesses?
Venture capital funding declined in the second quarter for the life sciences sector. Read more about how medical device startups and biotech companies fared.
Hatteras Venture Partners, a venture capital firm, will invest $20 million to $30 million in helping companies through first-in-man and preclinical studies. The firm expects to invest in 10 to 15 companies in the healthcare business.
Venture capital investment by corporations in the healthcare sector fell in the first quarter, but that may improve since the Affordable Care Act was upheld. Read more about investments in the healthcare sector.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.